10801 University Boulevard
ATCC is a private, nonprofit, global biological resource center and standards organization. We provide the scientific community credible biological products, advanced model systems, and high-quality services that support complex research in a variety of innovative applications resulting in incredible achievements in basic science, drug discovery, translational medicine, and public health.
We support the scientific community with the world’s largest and most diverse collection of human and animal cell products, as well as molecular genomic tools, microbe products, and biological materials. We offer a host of services, as well, including cell and microbial culturing and authentication, development and production of controls and derivatives, proficiency testing, and biomaterial deposit services. Through our ATCC Federal Solutions initiative, we lend our expertise to federal agencies in areas that include global health and infectious diseases, biodefense, and noncommunicable diseases.
We've developed a quality commitment, which includes ISO accreditations and standards, that has allowed ATCC to evolve from a traditional culture collection founded in 1925 to a biological resource center with an infrastructure that supports the future of life science and biotechnology.
Our newly expanded headquarters and bioproduction facility is located in Manassas, Virginia, near Washington DC, and a recently renovated research and technology center of excellence in Gaithersburg, Maryland.
ATCC - Credible Leads to Incredible
23 articles about ATCC
ATCC and Tissue Dynamics Announce a Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market
ATCC and Tissue Dynamics today announced a partnership to develop workflow friendly cardiac organoids-based kits for improved cardiac safety testing in drug development.
ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen
ATCC today announced a five-year, $87 million award from the Biomedical Advanced Research and Development Authority ( BARDA ), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support the development of next-generation medical countermeasures (MCMs) to protect Americans from public health security threats such as coronaviruses.
MSA-2003-ISS, developed in collaboration with the University of Vermont, becomes the first ATCC product in space.
ATCC Announces Award from National Institute of Allergy and Infectious Diseases to Support Its Preclinical Services for Biopharmaceutical Product Development
ATCC , the world’s premier biological materials management and standards organization, today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75N93023D00009 by the National Institute of Allergy and Infectious Diseases ( NIAID ), part of the National Institutes of Health (NIH).
Synthego, a leading genome engineering company, is pleased to announce a groundbreaking partnership with ATCC.
ATCC Announces New Award from BARDA to Further Support its Medical Countermeasures Clinical Studies Network
ATCC, the world’s premier biological materials management and standards organization, announced a Task Order award with the Biomedical Advanced Research and Development Authority, a component of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services.
Scott Boller, CPA, brings more than 25 years of financial and accounting leadership in the tech, software, and pharmaceutical industries to ATCC.
ATCC Announces New Award from the National Cancer Institute to Process Biomaterials for Cancer Research
ATCC today announced that it has been selected as an awardee for the National Cancer Institute’s (NCI) Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services contract.
Promotes Rebecca Bradford to Vice President, Government Programs and Linda Johnson to Vice President of Licensing and Intellectual Property.
ATCC Awarded Two Contracts from Gennova Biopharmaceuticals for the Continued Development of Cell Banks to Help Diagnose and Prevent Leishmaniasis
ATCC to collaborate with Gennova Biopharmaceuticals, the U.S. Food and Drug Administration, Ohio State University, and McGill University on a Leishmania donovani diagnostic test and Leishmania major vaccine.
ATCC, the world’s premier biological materials management and standards organization, announced that it has entered into an agreement with QIAGEN, a recognized leader in bioinformatics solutions, to provide them with sequencing data from its collection of cell lines, and animal and human biological materials.
11/22/2019Pharma and biotech companies strengthen their leadership teams and boards with this week's appointments.
This model is part of a larger effort by ATCC researchers to develop a portfolio of clinically relevant models and biomaterials for therapeutic discovery and development.
American Type Culture Collection (ATCC) And One Codex Form Collaboration To Address Challenges Of Microbiome Research
American Type Culture Collection (ATCC) Opens Doors To New High-Tech Biorepository In Gaithersburg, MD
American Type Culture Collection (ATCC) And BioAgilytix Labs Announce Partnership To Develop Custom Cell-Based Assay Solutions To Support Biopharmaceutical R&D
American Type Culture Collection (ATCC) Wins Multimillion Dollar Contract To Manage And Operate One Of The World's Largest Repositories Of Biological Specimens
American Type Culture Collection (ATCC) Launches Custom Cell Lines Funded By The Michael J. Fox Foundation For Parkinson's Research
American Type Culture Collection (ATCC) Signs CRADA With NIST To Validate Genetic Identification Technique For Mouse Cell Lines